Written by: Dr. Akash Chandawarkar, Board Certified Plastic Surgeon, Mirror Plastic Surgery | Last updated: September 9, 2026
Key Takeaways About Bioidentical Hormones
- Many doctors hesitate to prescribe compounded bioidentical hormones because of regulatory gaps, dosing variability, and limited long-term safety data, while FDA-approved options remain widely available.
- The term “bioidentical” refers only to molecular structure. Both FDA-approved and compounded products can contain bioidentical hormones, yet they follow very different quality and safety standards.
- Major medical organizations, including NAMS, ACOG, and the Endocrine Society, consider saliva testing unreliable for hormone dosing, which adds to physician reluctance.
- Compounded bioidentical hormones may fit narrow situations such as documented allergies to ingredients in FDA-approved products or unavailable commercial doses, rather than routine first-line therapy.
- If your current provider is not giving you the time or answers you need, schedule a consultation with Ellie at Mirror Plastic Surgery for personalized, medically supervised hormone therapy.
The Short Answer: Why Your Doctor Said No
Doctors do prescribe FDA-approved bioidentical hormones. Many avoid custom-compounded versions because of regulatory gaps, inconsistent dosing, and limited safety evidence. Major medical organizations including The Menopause Society and ACOG recommend FDA-approved options over compounded preparations. Understanding this distinction is the first step to getting the treatment you need. To see why the distinction matters, it helps to compare the two categories in detail.
FDA-Approved Vs. Compounded Bioidentical Hormones: Key Differences
The word “bioidentical” describes one thing: the hormone’s molecular structure matches what your body naturally produces. It does not describe how the hormone was made, how it was tested, or whether regulators reviewed it. Both FDA-approved and compounded products can contain bioidentical hormones, yet they follow very different standards.
FDA-approved bioidentical hormones function like standardized medications from a major pharmacy, manufactured under strict quality controls with consistent dosing. Compounded versions resemble a tailor-made blend from a specialty lab, customized for one person but without the same level of oversight. The FDA does not verify the safety, potency, or consistency of compounded drugs before they reach patients. The table below summarizes the main differences in oversight, evidence, dosing consistency, and cost.
| Feature | FDA-Approved Bioidentical Hormones | Compounded Bioidentical Hormones |
|---|---|---|
| Regulatory Oversight | FDA-reviewed for safety, efficacy, and manufacturing quality | Not FDA-reviewed before sale, regulated at state level (503A) or as outsourcing facilities (503B) |
| Safety Evidence | Extensive clinical trial data and post-market monitoring | Limited; 2020 NASEM report found insufficient evidence for routine use |
| Dosing Consistency | Batch-tested for potency and purity under cGMP standards | Can vary from batch to batch; FDA testing found 33% of samples failed potency testing |
| Typical Monthly Cost | $20–$60 with insurance for generics | $75–$300+ out of pocket, rarely covered by insurance |
Examples of FDA-approved bioidentical hormones include estradiol patches (Vivelle-Dot, Climara), oral micronized progesterone (Prometrium), vaginal estradiol (Estrace, Vagifem), and the combination capsule Bijuva. Estriol-containing products such as Biest are compounded by definition, since no FDA-approved estriol product exists in the United States.
Why Doctors Hesitate To Prescribe Compounded Bioidentical Hormones
Several distinct factors drive physician hesitation, and each one shapes how they approach your care.
- Lack Of FDA Oversight For Compounded Versions. Custom-compounded hormones bypass the FDA’s pre-market review for safety, purity, and effectiveness, and the FDA does not verify their quality before they reach patients.
- Limited Evidence For Added Benefit. The 2020 National Academies of Sciences, Engineering, and Medicine report found no high-quality evidence that compounded bioidentical hormones are safer or more effective than FDA-approved options, and ACOG’s 2023 Clinical Consensus states compounded bioidentical menopausal hormone therapy “should not be prescribed routinely when FDA-approved formulations exist.”
- Concerns About Saliva Testing. Many compounding practitioners use salivary hormone tests to guide dosing. The Menopause Society explicitly states that salivary hormone testing to determine dosing is “unreliable and not recommended.”
- Medical Liability And Training Gaps. Obstetrics and gynecology training programs globally have been identified as providing inadequate menopause education, leaving many practitioners unprepared for nuanced hormone therapy discussions. When this lack of training combines with liability concerns about unregulated products, many doctors default to “no.”
- Time Constraints In Standard Visits. Clinical barriers to hormone therapy discussion include time limits and competing priorities in consultations, so symptoms and treatment options often remain unaddressed unless the patient raises them directly.
If your doctor dismissed your symptoms or labeled hormone therapy universally dangerous, they may rely on outdated data. The 2002 Women’s Health Initiative studied oral conjugated equine estrogens combined with medroxyprogesterone acetate, a synthetic progestin, rather than today’s bioidentical estradiol and micronized progesterone approach, and these molecular and delivery differences affect risk and tolerability.
The Role Of Saliva Testing In Hormone Therapy
Compounding pharmacies often pair their products with salivary hormone tests that NAMS, ACOG, and the Endocrine Society consider clinically uninterpretable for dosing decisions. This concern is echoed in the 2017 Endocrine Society Scientific Statement on compounded bioidentical hormones, which concluded there is “no scientific basis for using compounded hormones rather than FDA-approved hormones,” citing dosing variability, contamination risk, and lack of package inserts. The 2020 NASEM report went further, flagging the pattern of using non-validated saliva or hair tests to justify custom-compounded hormone cocktails as “doing more marketing than medicine.”
How To Talk To Your Doctor About Bioidentical Hormones
Clear, calm language helps you and your doctor work as a team. Before your appointment, track your symptoms, note when they started, rate their severity, and review your full medical history including current medications. The conversation starters below keep the focus on collaboration.
- Opening The Conversation: “I have been experiencing [specific symptoms such as hot flashes waking me three times a night or brain fog affecting my work]. I have researched bioidentical hormones and would like to discuss whether they might be right for me. Please explain the difference between FDA-approved and compounded options.”
- Asking About Options: “If you are not comfortable prescribing compounded bioidentical hormones, would you consider an FDA-approved bioidentical option like estradiol or micronized progesterone?”
- Requesting A Referral: “Can you refer me to a menopause-competent provider if you do not feel equipped to manage this?”
- Responding To A Flat “No”: “Can you walk me through the reasoning for my case specifically? I want to understand the risks and benefits given my health history.”
Explore a consultation with Ellie if your current provider is not giving you the time or answers you need.
When Compounded Bioidentical Hormones Make Sense
Compounded versions have legitimate, narrow uses in modern care. The 2020 NASEM report and ACOG both identify two appropriate circumstances: a documented allergy to an inactive ingredient in an FDA-approved product, or a clinical need for a dose or formulation not commercially available. Even in these cases, medical supervision and careful sourcing remain critical. No major medical organization recommends compounded hormones as a routine first-line choice.
Questions To Ask Before Starting Any Hormone Therapy
Every woman benefits from asking a few core questions before starting hormone therapy, whether the product is FDA-approved or compounded.
- What are the potential risks and side effects specific to my health history?
- How will you monitor my progress and adjust my dose?
- What is your experience prescribing bioidentical hormones?
- Are you recommending an FDA-approved or compounded version, and what is your reasoning?
- Will my insurance cover this, and what are the likely out-of-pocket costs?
- How soon should I expect symptom relief, and what follow-up schedule do you recommend?1
Finding A Provider Who Truly Listens
Finding a menopause-competent provider becomes easier when you know the signs of thoughtful care. Green flags include taking a full history, explaining the difference between FDA-approved and compounded products, and discussing risks and limits openly. They also build in follow-up and keep the focus on symptom relief plus safety.
Mirror Plastic Surgery exemplifies the concierge approach that menopause care often requires. Dr. Akash Chandawarkar, a board-certified plastic surgeon who graduated with Honors from Harvard Medical School and completed a seven-year integrated residency at Johns Hopkins, offers personalized, medically supervised hormone therapy as part of a comprehensive wellness approach. His practice dedicates up to an hour to each consultation, conducts in-depth lab analysis, and provides ongoing support. Every protocol is designed around each patient’s labs and physiology and remains medically supervised throughout. Consultations are available in person in St. Petersburg, FL, or remotely across the United States.

Frequently Asked Questions
Why Won’t My Doctor Put Me On HRT?
Many doctors still rely on concerns that came from the 2002 Women’s Health Initiative, which studied synthetic hormones such as conjugated equine estrogens and medroxyprogesterone acetate. Those findings were later misapplied to all hormone therapy. Most physicians also receive minimal menopause training and may not feel confident with current evidence supporting FDA-approved bioidentical hormones for women under 60 or within 10 years of menopause onset. Tight appointment schedules further limit time for nuanced hormone discussions.
Do Regular Doctors Prescribe Bioidentical Hormones?
Many primary care doctors and gynecologists prescribe FDA-approved bioidentical hormones such as estradiol patches and micronized progesterone capsules. They often decline custom-compounded versions because of the regulatory and safety concerns discussed earlier. The key distinction is regulatory rather than chemical, since both types can contain molecularly identical hormones, yet only FDA-approved products undergo pre-market review for safety, efficacy, and manufacturing quality.
What Is The Safest Bioidentical Hormone Replacement?
For many women, FDA-approved bioidentical hormones, particularly transdermal estradiol combined with oral micronized progesterone, offer the most evidence-supported safety profile.1 Transdermal delivery avoids first-pass liver metabolism, which can affect clotting factors and cardiovascular risk.1 The Endocrine Society and The Menopause Society recommend these over compounded preparations, which lack the same quality controls and safety monitoring. The right choice always depends on an individual’s health history, symptoms, and risk profile.
Are Compounded Bioidentical Hormones Safe?
Compounded bioidentical hormones can be appropriate in specific situations, such as a documented allergy to an ingredient in an FDA-approved product or a need for a dose or formulation not commercially available. Outside those narrow circumstances, they lack FDA oversight, can vary in potency and purity from batch to batch, and have not undergone rigorous pre-market safety testing. The 2020 NASEM report found insufficient evidence to support their routine use, and the potency failure rate mentioned earlier highlights why careful selection and monitoring matter.
What Is The Difference Between Bioidentical And Synthetic Hormones?
Bioidentical hormones have the same molecular structure as hormones your body naturally produces, primarily estradiol and progesterone. Synthetic hormones, such as conjugated equine estrogens and medroxyprogesterone acetate, have different chemical structures and may bind to receptors differently, which can change risk and tolerability profiles. The 2002 Women’s Health Initiative focused on synthetic hormones, so its findings do not directly apply to modern bioidentical regimens.
Can A Plastic Surgeon Prescribe Bioidentical Hormones?
Board-certified physicians, including plastic surgeons, can prescribe hormone therapy within their scope of practice. Dr. Akash Chandawarkar at Mirror Plastic Surgery offers medically supervised hormone therapy as part of a comprehensive wellness approach, combining his background in neuroscience, medical innovation, and surgical physiology with concierge-level patient care. Every protocol is grounded in lab analysis and tailored to the individual patient’s physiology and goals.
You Deserve Treatment That Works
Bioidentical hormones are available and, for many women, appropriate, yet the FDA-approved versus compounded distinction carries major implications for safety, consistency, and evidence. Doctors may hesitate for regulatory and training reasons, and that hesitation can change over time as you ask questions and share updated information. You have the right to seek clear explanations, request referrals, and choose providers who are prepared to manage menopause care thoughtfully.
Women are increasingly demanding better menopause care, and usage patterns reflect that shift. US outpatient hormone therapy use nearly doubled from 1.7% of women in January 2017 to 3.6% by April 2026, with growth accelerating after 2022, driven in part by patients advocating for themselves. You can join that movement and advocate for care that matches your symptoms and goals.
If you feel ready to explore bioidentical hormone therapy with a provider who takes your symptoms seriously, consider a visit with Mirror Plastic Surgery in St. Petersburg, FL, or a remote consultation across the United States.
Schedule Your Appointment With Ellie
This article is for educational purposes only and does not replace individualized medical advice. Consult a qualified healthcare provider to discuss your specific symptoms, health history, and treatment options.
1 Results may vary from person to person. Editorial content, before and after images, and patient testimonials do not constitute a guarantee of specific results.
Peptide therapy is intended for wellness and optimization purposes and is not prescribed to diagnose, treat, cure, or prevent disease unless specifically stated. Many peptides are not FDA-approved and may be used off-label. Some have limited long-term safety data, with a potential for unknown risks, complications, or desensitization with prolonged use.

